{"TopicDetails": {"type": 0, "ccm2Id": 46982444, "cftId": 0, "identifier": "EU4H-2024-PJ-02-2", "title": "Call for Proposals to increase health literacy for cancer prevention and care - CR-g-24-39", "publicationDateLong": 1718668800000, "callIdentifier": "EU4H-2024-PJ-02", "callTitle": "EU4H Action Grants 2024", "callccm2Id": 46908104, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 44176631, "abbreviation": "Improving", "description": "Improving the availability, accessibility and affordability of medicinal products and medical devices, and crisis-relevant products in the Union"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "18 June 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["10 October 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3543022": [{"action": "EU4H-2024-PJ-02-4 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}], "3543024": [{"action": "EU4H-2024-PJ-02-3 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 7400000}, "budgetTopicActionMap": {}}], "3543026": [{"action": "EU4H-2024-PJ-02-1 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 8000000}, "budgetTopicActionMap": {}}], "3543028": [{"action": "EU4H-2024-PJ-02-2 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p>The main objective of this action is to support health literacy for cancer prevention and care, to improve health literacy and to focus on reducing inequalities in cancer prevention and care.</p><p>This action supports the implementation of the Europe\u2019s Beating Cancer Plan objective to launch a project on \u2018Health Literacy for Cancer Prevention and Care\u2019 and implements the EU4Health Programme\u2019s general objective of improving and fostering health in the Union (Article 3, point (a), of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, point (a), of Regulation (EU) 2021/522.</p><p>The action should aim to:</p><ul level=\"0\"><li>improve health literacy of citizens, of patients of all ages, as well as of healthcare professionals;</li><li>improve health literacy of citizens on cancer prevention and provide them access to adequate and reliable health information in order to empower them to make informed decisions supporting healthy lifestyles and improving health for all citizens of all ages;</li><li>improve health literacy of patients by providing adequate, reliable, and timely information on their diagnosis and treatment to achieve their disease understanding and active involvement in the treatment; improve health literacy in palliative care;</li><li>improve health literacy education of health professionals:   <ol style=\"list-style-type:lower-alpha\" level=\"1\">    <li>raising awareness of the impact low health literacy can have on people at risk of cancer and cancer patients;</li><li>providing healthcare professionals with health-literacy-friendly communication techniques to support their interactions with cancer patients.</li>   </ol> </li> </ul><p>Provide access to reliable, accurate and easy-to understand information to:</p><ol style=\"list-style-type:lower-alpha\" level=\"0\">  <li>improve access to reliable, accurate cancer information in different languages, with attention to varying digital and literacy skills and accessibility;</li><li>improve access to reliable, accurate information on the internet, to combat misinformation available online / in social media to educate and protect citizens and patients from misinformation on the Internet and social media;</li><li>support cancer literacy in relation to emotional impact and psychosocial distress of cancer patients;</li><li>build a 'Virtual library' on communication in cancer prevention and care;</li><li>reduce medical jargon and improve education using plain language, easy-to-understand written materials, including visuals to provide more culturally and linguistically appropriate health education and enhanced web-based information.</li> </ol><p>Promote health literacy, exchange of information and best practices to:</p><ol style=\"list-style-type:lower-alpha\" level=\"0\">  <li>introduce a cancer health literacy day to raise awareness and promote its importance;</li><li>support the generation and dissemination of evidence and good practices, including at population level;</li><li>gather lessons learned to enhance health literacy in general, for example, through the establishment of cancer literacy projects;</li><li>get an overview of health literacy programmes developed within healthcare systems and in the community;</li><li>reflect on the role of health literacy in cancer prevention and care, potential gaps, and recommendations for action;</li><li>promote collaboration and exchange of information, innovations and experience on cancer health literacy between Member States and other relevant stakeholders.</li> </ol>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>This action contributes to the implementation of the Europe\u2019s Beating Cancer Plan.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>The expected result is the launch of projects to increase health literacy for cancer prevention and care.</p><p>This action will increase health literacy of the general population, patients, and health care specialists in the area of cancer prevention and care, will enable citizens to take informed decisions as regards prevention and screening, will help patients to take active involvement in treatment and will help health-care specialists to transmit the information in an easy-to understand way.</p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the call document</span>&nbsp;</p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the call document</span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the call document</span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the call document</span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the call document</span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the call document</span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the call document</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2024/call-fiche_eu4h-2024-pj-02_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Standard application form ([ToA])</a>&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsx\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Detailed budget table ([ToA])</a></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">EU4Health Programme General MGA v1.1</a></span></p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span class=\"MsoHyperlink\" style=\"box-sizing: inherit;\"><span style=\"box-sizing: inherit;\"><a href=\"https://health.ec.europa.eu/publications/2024-eu4health-work-programme_en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">EU4Health Work Programme 2024</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU4Health&nbsp;</span></a><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Regulation 2021/522</a></span></span><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><br style=\"box-sizing: inherit;\" />\r\n</span><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU Financial Regulation 2018/1046</span></a></p>\n", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><a href=\"mailto:HaDEA-HP-CALLS@ec.europa.eu\" target=\"_blank\" style=\"color: rgb(40, 151, 183); font-family: Arial, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">HaDEA-HP-CALLS@ec.europa.eu</a></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "EU4H-2024-PJ-02", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "EU4H-PJG", "criterionDescription": "EU4H Project Grants", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/37342?topic=EU4H-2024-PJ-02-2", "startDate": "Jun 18, 2024 12:00:00 AM", "endDate": "Oct 10, 2024 5:00:00 PM", "mgaDescription": "EU4H Action Grant Budget-Based", "mgaCode": "EU4H-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>&nbsp;<span style=\"text-align: justify; font-size: 10pt; font-family: Verdana, sans-serif;\">On 24 March 2021, the EU4Health Regulation was adopted as part of the EU Multiannual Financial Framework for the 2021-2027 period. The EU4Health Regulation established 'the EU4Health Programme'. This marks an important step towards making available instruments and solutions to support Member States in building stronger, more resilient and accessible health systems.&nbsp;</span><span lang=\"EN-GB\" style=\"text-align: justify; font-size: 10pt; font-family: Verdana, sans-serif;\">&nbsp;</span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">The EU4Health Programme represents an unprecedented level of financial commitment for the EU in health in comparison with previous health programmes. The Programme is EU's response to the current public health emergency that will make a significant contribution to the post-COVID-19 recovery aiming to:</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- improve public health in the Union through disease prevention and health promotion, as well as international health initiatives and cooperation;</span><span lang=\"EN-GB\" style=\"font-size:&#10;10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:Verdana;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- protect people from serious cross-border health threats through prevention, preparedness and response to cross-border health threats; complementing national stockpiling of essential crisis-relevant products; and establishing a reserve of medical, healthcare and support staff;</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- improve access to medicinal products, medical devices and crisis-relevant products by encouraging sustainable production and supply chains and innovation in the Union and efficient use of medicinal products;</span><span lang=\"EN-GB\" style=\"font-size:&#10;10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:Verdana;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- strengthen the national health systems through improved health data use and re-use, development of digital tools and services, digital transformation of healthcare; enhancing access to healthcare; developing and implementing EU health legislation and evidence-based decision making; and integrated work among Member States' health systems.</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;&#10;mso-bidi-font-family:Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-GB\"><o:p></o:p></span></p>", "latestInfos": [{"approvalDate": "Jun 18, 2024 12:00:01 AM", "lastChangeDate": "Jun 18, 2024 12:00:01 AM", "content": "The submission session is now available for: EU4H-2024-PJ-02-1(EU4H-PJG), EU4H-2024-PJ-02-3(EU4H-PJG), EU4H-2024-PJ-02-2(EU4H-PJG), EU4H-2024-PJ-02-4(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}